COVID-19 Update: Information and resources can be found here.

Clinical Research

Dr. Byron Cryer

Byron Cryer, M.D.
Research Interests: Pathogenesis of peptic ulcer disease


Dr. Kerry Dunbar

Kerry Dunbar, M.D., Ph.D.
Research Interests: Barrett's esophagus, Eosinophilic esophagitis, Esophageal motility disorders, Gastroesophageal reflux disease, and Novel endoscopic imaging


Dr. David Fudman

David Fudman, M.D.
Research Interests: Inflammatory bowel disease and Quality improvement


Dr. Nisa Kubiliun

Nisa Kubiliun, M.D.
Research Interests: Pancreatic cancer early detection and prevention, genetic risk for pancreatic malignancies


Dr. William M. Lee

William Lee, M.D
Research Interests: Acute liver failure, Drug-induced hepatotoxicity, Hepatitis B, Hepatitis C
Acute Liver Failure Study Group


Dr. Jorge Marrero

Jorge Marrero, M.D.
Research Interests: Hepatocellular carcinoma, Liver transplantation


Dr. 
Marlyn Mayo

Marlyn Mayo, M.D.
Research Interests: Autoimmune liver diseases, Liver Disease in Pregnancy, Primary biliary cirrhosis


Dr. Mack Mitchell

Mack Mitchell, M.D.
Research Interests: Alcohol-related liver disease


photo of Caitlin Murphy

Caitlin Murphy, Ph.D.
Research Interests: Understanding the causes and outcomes of colorectal cancer


photo of Dr. Jacqueline O'Leary

Jacqueline O'Leary, M.D.
Research Interests: Acute-on-Chronic Liver Failure, Antibody Mediated Rejection in Liver Transplantation, NASH


photo of Dr. Nicole Rich

Nicole Rich, M.D.
Research Interests: Hepatitis C screening in underserved populations, Hepatocellular carcinoma (HCC) prognosis and treatment, Racial/ethnic disparities in liver diseases


photo of Dr. Amit Singal

Amit Singal, M.D.
Research Interests: Effectiveness of surveillance for hepatocellular carcinoma, Impact of patient and physician knowledge/attitudes on receipt of care, Quality of care in the cirrhotic patient


photo of Dr. Anna Tavakkoli

Anna Tavakkoli, M.D.
Research Interests: Disparities in gastrointestinal malignancies, quality improvement of ERCP, and outcomes after ESG and TORe